Hot Topics

Poll

Governments can ration access to cancer drugs, or break patent monopolies. Why is rationing so popular?:

WTO TRIPS Council (February 2015): LDC Group statement on Non-Violation and Situation Complaints

On Tuesday, 24 February 2015, Bangladesh, on behalf of the LDC Group delivered the following statement on non-violation and situation complaints.

AGENDA 6: NON-VIOLATION AND SITUATION COMPLAINTS

Mr. Chairman,

I am taking floor on behalf of the LDC group.

LDCs are concerned that non-violation and situation complaints may pose unnecessary problems to LDCs which can be otherwise avoidable if we do not implement this provision under TRIPS.

WTO TRIPS Council (February 2015): LDC request for extension of the transitional period for pharmaceutical products

The World Trade Organization (WTO) is convening the TRIPS Council from Tuesday, 24 February 2015 to Wednesday, 25 February 2015. As mentioned in a previous piece, Norway and the United States "have submitted a written request for the inclusion of the topic, "Intellectual Property and Innovation: Women And Innovation" (Source: WTO TRIPS Council-February 2015- Norway and the United States bring gender mainstreaming to the fore-Women and Innovation, http://keionline.org/node/2167).

WTO Trade Policy Review of the United States: USTR deflects questions from India on compulsory licensing (December 2014)

On 16 December 2014 and 18 December 2014, the World Trade Organization (WTO) undertook a trade policy review of the United States of America. All members of the WTO are subject to review under the Trade Policy Review Mechanism (TPRM).

Human Rights Council Social Forum 2015: Intervention of Knowledge Ecology International

20 February 2015

In accordance with Human Rights Council resolution A/HRC/RES/26/28, the Human Rights Council convened the 2015 Social Forum at the United Nations Palais des Nations in Geneva from 18-20, February 2015 with a focus on "access to medicines in the context of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health, including best practices in this regard."

Save the Date- 19 February 2015- Fire in the Blood- Screening co-sponsored by KEI/MSF-Access Campaign

The Human Rights Council's 2015 Social Forum will take place from 18 February 2015 to 20 February 2015 at the Palais des Nations in Geneva, Switzerland.

As requested by the Council in the above-mentioned resolution, the 2015 Social Forum will focus on "access to medicines in the context of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health, including best practices in this regard ". (Source: http://www.ohchr.org/EN/Issues/Poverty/SForum/Pages/SForum2015.aspx).

Regional Comprehensive Economic Partnership, Japan IPR proposals, October 3, 2014

Attached is a leaked version of Japan's October 3, 2014 proposals for intellectual property for the Regional Comprehensive Economic Partnership.

The Regional Comprehensive Economic Partnership (RCEP) is a proposed free trade agreement (FTA) between the ten member states of the Association of Southeast Asian Nations (ASEAN) (Brunei, Burma (Myanmar), Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam) and the six states with which ASEAN has existing FTAs (Australia, China, India, Japan, South Korea and New Zealand).

KEI 2015 Special 301 Comments (filed February 6, 2015)

Attached are KEI's February 6 comments to USTR on the 2015 Special 301.

Our 7 page submission begins with this:

KEI comments on India IP strategy

Attached are KEI's January 30, 2015 comments on the India IP Policy.

http://keionline.org/sites/default/files/KEI_30Jan2015_Comments_India_IPR_Policy.pdf

This is how the comments begin:

Knowledge Ecology International (KEI) has reviewed the document entitled “National IPR Policy” prepared by the IPR Think Tank. The document is surprisingly lacking in several key areas. In particular:

On World Cancer Day, do we celebrate the approval of Pfizer's $118,200 drug Ibrance?

Today, on World Cancer Day, there has been many great announcements and celebrations.

The FDA approved Pfizer's new drug Ibrance (INN: palbociclib) for the treatment of metastatic (advanced) breast cancer to be used in combination with letrozole based on a 165 person trial at UCLA's cancer center. (FDA press release here, ABC story here.)

WTO TRIPS Council (February 2015): Norway and the United States bring gender mainstreaming to the fore-Women and Innovation

The first session of the 2015 World Trade Organization's TRIPS Council takes place from 24 February 2015 to 25 February 2015. Like clockwork, the United States has tabled the inclusion of an additional item on Intellectual Property and Innovation. This marks the 8th time since November 2012 that the United States has submitted the inclusion of an additional agenda item to the TRIPS Council relating to intellectual property or innovation.

UACT letter to Professor DiMasi, asking for answer to five questions about new R&D cost study

February 4, 2015 is World Cancer Day. The rapidly increasing cost of cancer drugs should be broadly discussed. The Union for Affordable Cancer Treatment (UACT), a union of people affected by cancer (http://cancerunion.org/) is asking the author and co-author of the "Tufts Cost Study," --a not-yet-released "study" used to justify high prices of drugs without providing data-- to address the following questions:

EB 136 Draft decision passed on the Global Strategy and Plan of Action on Public Health, Innovation, and Intellectual Property

On Tuesday February 3, 2015, the final day of the 136th WHO Executive Board meeting, the EB passed a draft decision on the Global Strategy and Plan of Action on Public Health, Innovation, and Intellectual Property (GSPoA). The draft decision recommends to the WHA that the GSPOA be extended until 2022.

EB 136 Friday, January 30th: Discussion of Consultative Expert Working Group on Research Development-Financing and Coordination

Another matter considered during the Friday, January 30th session of the WHO Executive Board was the "Follow-up of the report on the Consultative Expert Working Group on Research Development-Financing and Coordination." In addition to the general report on the CEWG, the EB also considered the Director General's report on the CEWG "Health research and development demonstration projects."

EB 136 Friday, January 30th: Global Strategy and Plan of Action on Public Health, Innovation, and Intellectual Property

On Friday, January 30th, the WHO Executive Board discussed the Global Strategy and Plan of Action on Public Health, Innovation, and Intellectual Property (GSPA). The discussion covered several documents in relation to the GSPoA, including:

Syndicate content